What Viridian Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 2 | 3 |
| Total trades | 4 | 18 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 50,000 | 1,265,672 |
| Disposed | 14,212 | 45,226 |
| Net activity | +35,788 | +1,220,446 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tousignant Jennifer | Chief Legal Officer | Aug 19 | Open-market sale · S | −10,000 | $24.50 | −$245K | 0 |
| Tousignant Jennifer | Chief Legal Officer | Aug 19 | Exercise / conversion · M | +10,000 | $14.41 | +$144K | 10,000 |
| Tousignant Jennifer | Chief Legal Officer | Aug 19 | Open-market sale · S | −4,212 | $24.50 | −$103K | 0 |
| Tripuraneni Radhika | Chief Medical Officer | Aug 14 | Exercise / conversion · M | +40,000 | $13.21 | +$528K | 40,000 |
| Fairmount Funds Management Llc | Director | May 11 | Open-market buy · P | +1,176,470 | $17.00 | +$20M | 5,090,928 |
| Mahoney Stephen F. | President and CEO | Mar 03 | Withheld — tax / exercise cost · F | −7,627 | $29.32 | −$224K | 33,130 |
| Mahoney Stephen F. | President and CEO | Mar 03 | Exercise / conversion · M | +18,357 | — | — | 40,757 |
| Beetham Thomas W. | Chief Operating Officer | Mar 03 | Withheld — tax / exercise cost · F | −3,138 | $29.32 | −$92K | 13,271 |
| Beetham Thomas W. | Chief Operating Officer | Mar 03 | Exercise / conversion · M | +9,409 | — | — | 16,409 |
| Mahoney Stephen F. | President and CEO | Mar 03 | Withheld — tax / exercise cost · F | −7,408 | $30.19 | −$224K | 33,349 |
| Beetham Thomas W. | Chief Operating Officer | Mar 03 | Withheld — tax / exercise cost · F | −3,048 | $30.19 | −$92K | 13,361 |
| Harmon Seth | Chief Financial Officer | Mar 03 | Withheld — tax / exercise cost · F | −2,091 | $29.32 | −$61.3K | 7,790 |
| Harmon Seth | Chief Financial Officer | Mar 03 | Exercise / conversion · M | +6,267 | — | — | 9,881 |
| Harmon Seth | Chief Financial Officer | Mar 03 | Withheld — tax / exercise cost · F | −2,031 | $30.19 | −$61.3K | 7,850 |
| Tousignant Jennifer | Chief Legal Officer | Mar 03 | Withheld — tax / exercise cost · F | −1,724 | $29.32 | −$50.5K | 3,445 |
| Tousignant Jennifer | Chief Legal Officer | Mar 03 | Exercise / conversion · M | +5,169 | — | — | 5,169 |
| Tousignant Jennifer | Chief Legal Officer | Mar 03 | Withheld — tax / exercise cost · F | −1,675 | $30.19 | −$50.6K | 3,494 |
| Tousignant Jennifer | Chief Legal Officer | Dec 31 | Open-market sale · S | −2,272 | $31.16 | −$70.8K | 0 |
| Fairmount Funds Management Llc | Director | Oct 23 | Open-market buy · P | +454,545 | $22.00 | +$10M | 3,914,458 |
| Fairmount Funds Management Llc | Director | Jun 10 | Exercise / conversion · M | +12,500 | $12.31 | +$154K | 3,459,913 |
Loading...
